Millennium Management’s Allergan plc AGN Stock Holding History

Millennium Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-140,000	Closed	-$26.8M	–	4844
2019 Q4	$26.8M	Sell	140,000 -35,000	-20%	-$6.31M	0.03%	671
2019 Q3	$29.4M	Buy	+175,000	New	+$28.5M	0.05%	567
2015 Q2	–	Sell	-5,200	Closed	-$1.55M	–	4044
2015 Q1	$1.55M	Buy	+5,200	New	+$1.48M	﹤0.01%	2098
2014 Q1	–	Sell	-9,700	Closed	-$1.63M	–	4064
2013 Q4	$1.63M	Buy	9,700 +5,500	+131%	+$860K	0.01%	1958
2013 Q3	$605K	Buy	+4,200	New	+$559K	﹤0.01%	2419

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Millennium Management's AGN Position: Q2 2020 in Review

Millennium Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,869,196 shares — an estimated $685M sold.

Millennium Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $685M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Millennium Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Millennium Management sold 3,869,196 Allergan plc shares in Q2 2020, an estimated $685M.
Millennium Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
Millennium Management's Allergan plc position peaked at $685M in Q1 2020.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.